Industry welcomes boost to health research in UK budgetGroups representing the biopharma industry have welcomed an increase in health-specific R&D to £5 billion in the UK Share XIndustry welcomes boost to health research in UK budgethttps://pharmaphorum.com/news/industry-welcomes-boost-to-health-research-in-uk-budget/
Dementia, cancer headline UK’s 10-year plan for life sciences sectorThe UK’s long-awaited Life Sciences Vision strategy has been published, setting out the government’s stall as it tries Share XDementia, cancer headline UK’s 10-year plan for life sciences sectorhttps://pharmaphorum.com/news/dementia-cancer-headline-uks-10-year-plan-for-life-sciences-sector/
UK biotech ‘booming’ as sector rakes in £1.6bn in Q2 financingThe UK’s biotechnology sector is going through a purple patch, attracting almost £1.6 billion ($2.2 billion) in financing Share XUK biotech ‘booming’ as sector rakes in £1.6bn in Q2 financinghttps://pharmaphorum.com/news/uk-biotech-booming-as-sector-rakes-in-1-6bn-in-q2-financing/
UK highlights life sciences’ key role in post-COVID recoveryThe UK government used the Queen’s Speech to set out its ambition to make the country a leader Share XUK highlights life sciences’ key role in post-COVID recoveryhttps://pharmaphorum.com/news/uk-highlights-life-sciences-key-role-in-post-covid-recovery/
UK parliament backs EU trade deal, as industry sifts through detailThe post-Brexit trade deal agreed on Christmas Eve has been overwhelmingly backed by the UK parliament, providing some Share XUK parliament backs EU trade deal, as industry sifts through detailhttps://pharmaphorum.com/news/uk-parliament-backs-eu-trade-deal-as-industry-sifts-through-detail/
Sunak’s first budget tackles pharma R&D as well as coronavirusIn his first budget as UK chancellor, Rishi Sunak’s main focus was to prepare the country for the Share XSunak’s first budget tackles pharma R&D as well as coronavirushttps://pharmaphorum.com/news/sunaks-maiden-budget-tackles-pharma-rd-as-well-as-coronavirus/
UK reiterates post-Brexit EMA wishes – but reality gap remainsAnalysis: while Theresa May has acknowledged difficult trade-offs for the first time, her Brexit demands remain an impossible Share XUK reiterates post-Brexit EMA wishes – but reality gap remainshttps://pharmaphorum.com/news/uk-reiterates-post-brexit-ema-wishes-reality-gap-remains/
Brexit: just one month to agree transition deal, says UK pharmaThe UK pharma and biotech industries have warned that clarity on Brexit arrangements for medicines is needed urgently Share XBrexit: just one month to agree transition deal, says UK pharmahttps://pharmaphorum.com/news/brexit-just-one-month-agree-transition-deal-says-uk-pharma/
Boasting best pipeline in Europe, moment of truth arrives for UK biotechs in 2018A new report on the UK’s bioscience sector shows it enjoyed a strong 2017, with international investment fuelling Share XBoasting best pipeline in Europe, moment of truth arrives for UK biotechs in 2018https://pharmaphorum.com/views-and-analysis/money-flows-uk-biotech-confidence-grows/
